ÂÜÀòÂÒÂ×

Dhonghyo Kho currently serves as a Senior Scientist at Proteintech Group since April 2019 and is also a Postdoctoral Fellow at Karmanos Cancer Institute since 2009. Prior experience includes a Postdoctoral Research Fellow position at the National Cancer Center from 2008 to 2009, where significant research involved identifying a negative regulator relevant to T cell anergy, with findings published in Nature Communications. Dhonghyo Kho earned a PhD in Molecular Biology and Microbiology from Sogang University between 1998 and 2003, with a focus on enhancing CRISPR-Cas9 editing techniques during the current role at Proteintech Group.